Trial
NCT02516423
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Biologics, Inc.
Condition
Solitary Osseous Plasmacytoma
Intervention
ixazomib
Why stopped
DSMB recommendation due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30